Landing Point Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$577K Sell
628
-17
-3% -$17.2K 0.28% 44
2025
Q4
$694K Hold
645
0.35% 37
2025
Q3
$492K Buy
645
+206
+47% +$153K 0.26% 49
2025
Q2
$342K Buy
439
+5
+1% +$3.88K 0.22% 50
2025
Q1
$358K Sell
434
-32
-7% -$26.6K 0.27% 45
2024
Q4
$407K Buy
+466
New +$386K 0.31% 38

Other funds holding LLY

Landing Point Financial Group's LLY Position: Q1 2026 in Review

Landing Point Financial Group reduced its Eli Lilly (LLY) stake by 2.6% in Q1 2026, selling an estimated $17.2K and leaving 628 shares worth $577K. The position accounts for 0.28% of the portfolio, ranked #44.

Landing Point Financial Group first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $694K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Landing Point Financial Group held 628 shares of Eli Lilly worth $577K as of Q1 2026.
  • Landing Point Financial Group sold 17 Eli Lilly shares in Q1 2026, an estimated $17.2K.
  • Eli Lilly made up 0.28% of Landing Point Financial Group's portfolio in Q1 2026, its #44 holding.
  • Landing Point Financial Group first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • Landing Point Financial Group's Eli Lilly position peaked at $694K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Landing Point Financial Group's 13F filing for Q1 2026, filed 5 May 2026.